Farideh Miraki‐Moud

2.0k total citations
33 papers, 1.4k citations indexed

About

Farideh Miraki‐Moud is a scholar working on Endocrinology, Diabetes and Metabolism, Hematology and Molecular Biology. According to data from OpenAlex, Farideh Miraki‐Moud has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Hematology and 9 papers in Molecular Biology. Recurrent topics in Farideh Miraki‐Moud's work include Growth Hormone and Insulin-like Growth Factors (15 papers), Acute Myeloid Leukemia Research (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Farideh Miraki‐Moud is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (15 papers), Acute Myeloid Leukemia Research (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Farideh Miraki‐Moud collaborates with scholars based in United Kingdom, United States and Italy. Farideh Miraki‐Moud's co-authors include John G. Gribben, David Taussig, Dominique Bonnet, Jamie Cavenagh, Samir Agrawal, Heather Oakervee, Debra M. Lillington, Cecilia Camacho‐Hübner, Fernando Anjos‐Afonso and Emmanuel Griessinger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Farideh Miraki‐Moud

32 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Farideh Miraki‐Moud	610	583	321	295	264	33	1.4k
Angela Mariano	189 0.3×	554 1.0×	209 0.7×	148 0.5×	83 0.3×	41	995
Angela Russo	151 0.2×	537 0.9×	89 0.3×	142 0.5×	141 0.5×	38	1.0k
Betty Gardie	139 0.2×	803 1.4×	121 0.4×	194 0.7×	516 2.0×	36	1.3k
Ming-jiang Xu	337 0.6×	605 1.0×	80 0.2×	156 0.5×	70 0.3×	20	1.5k
Tomoo Ueno	175 0.3×	541 0.9×	327 1.0×	512 1.7×	139 0.5×	23	2.2k
Irene A. Rigault de la Longrais	141 0.2×	799 1.4×	112 0.3×	345 1.2×	435 1.6×	26	1.4k
Marianne E. Greene	558 0.9×	626 1.1×	32 0.1×	170 0.6×	128 0.5×	20	1.3k
Thomas Strömberg	206 0.3×	503 0.9×	168 0.5×	214 0.7×	151 0.6×	15	744
Khuda Dad Khan	128 0.2×	622 1.1×	74 0.2×	715 2.4×	127 0.5×	29	1.5k
Mona Shehata	160 0.3×	768 1.3×	40 0.1×	526 1.8×	269 1.0×	24	1.3k

Countries citing papers authored by Farideh Miraki‐Moud

Since Specialization

Citations

This map shows the geographic impact of Farideh Miraki‐Moud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farideh Miraki‐Moud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farideh Miraki‐Moud more than expected).

Fields of papers citing papers by Farideh Miraki‐Moud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farideh Miraki‐Moud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farideh Miraki‐Moud. The network helps show where Farideh Miraki‐Moud may publish in the future.

Co-authorship network of co-authors of Farideh Miraki‐Moud

This figure shows the co-authorship network connecting the top 25 collaborators of Farideh Miraki‐Moud. A scholar is included among the top collaborators of Farideh Miraki‐Moud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farideh Miraki‐Moud. Farideh Miraki‐Moud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Casado, Pedro, et al.. (2025). Phosphoproteomics identifies determinants of PAK inhibitor sensitivity in leukaemia cells. Cell Communication and Signaling. 23(1). 135–135. 1 indexed citations

Casado, Pedro, Ana Rio‐Machín, Juho J. Miettinen, et al.. (2023). Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. Signal Transduction and Targeted Therapy. 8(1). 80–80. 13 indexed citations

Halim, Leena, Farideh Miraki‐Moud, David Taussig, et al.. (2021). Priming Death Receptor Mediated Apoptosis with Arginine Starvation Sensitises Arginine Auxotrophic B-ALL to CAR-T. Blood. 138(Supplement 1). 2787–2787.

Moore, Andrew S., Amir Faisal, Grace Wing-Yan Mak, et al.. (2020). Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736. Blood Advances. 4(7). 1478–1491. 20 indexed citations

Ghazaly, Essam, Farideh Miraki‐Moud, Robert Petty, et al.. (2020). Repression of sphingosine kinase (SK)-interacting protein (SKIP) in acute myeloid leukemia diminishes SK activity and its re-expression restores SK function. Journal of Biological Chemistry. 295(16). 5496–5508. 7 indexed citations

Wodehouse, Theresa, Robert Petty, Farideh Miraki‐Moud, et al.. (2019). A randomized pilot study to investigate the effect of opioids on immunomarkers using gene expression profiling during surgery. Pain. 160(12). 2691–2698. 15 indexed citations

Casado, Pedro, Edmund H. Wilkes, Farideh Miraki‐Moud, et al.. (2018). Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells. Leukemia. 32(8). 1818–1822. 34 indexed citations

Potter, Nicola, Farideh Miraki‐Moud, Luca Ermini, et al.. (2018). Single cell analysis of clonal architecture in acute myeloid leukaemia. Leukemia. 33(5). 1113–1123. 56 indexed citations

Miraki‐Moud, Farideh, Fernando Anjos‐Afonso, Katharine Hodby, et al.. (2013). Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation. Proceedings of the National Academy of Sciences. 110(33). 13576–13581. 108 indexed citations

10.

David, Alessia, Stephen Rose, Farideh Miraki‐Moud, et al.. (2010). Acid-Labile Subunit Deficiency and Growth Failure: Description of Two Novel Cases. Hormone Research in Paediatrics. 73(5). 328–334. 24 indexed citations

11.

David, Alessia, Farideh Miraki‐Moud, N. Shaw, et al.. (2009). Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity. European Journal of Endocrinology. 162(1). 37–42. 13 indexed citations

12.

Taussig, David, Farideh Miraki‐Moud, Fernando Anjos‐Afonso, et al.. (2008). Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood. 112(3). 568–575. 278 indexed citations

13.

Camacho‐Hübner, Cecilia, Stephen Rose, Michael A. Preece, et al.. (2006). Pharmacokinetic Studies of Recombinant Human Insulin-Like Growth Factor I (rhIGF-I)/rhIGF-Binding Protein-3 Complex Administered to Patients with Growth Hormone Insensitivity Syndrome. The Journal of Clinical Endocrinology & Metabolism. 91(4). 1246–1253. 39 indexed citations

14.

Martinelli, Carlos Eduardo, et al.. (2006). Final Height in Patients with Idiopathic Short Stature and High Growth Hormone Responses to Stimulation Tests. Hormone Research in Paediatrics. 67(5). 224–230. 6 indexed citations

15.

Brooke, Antonia, et al.. (2006). Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement. Clinical Endocrinology. 65(5). 673–680. 18 indexed citations

16.

Chan, Li F., Helen L. Storr, Irene Scheimberg, et al.. (2004). Pseudo-precocious Puberty Caused by a Juvenile Granulosa Cell Tumour Secreting Androstenedione, Inhibin and Insulin-like Growth Factor-I. Journal of Pediatric Endocrinology and Metabolism. 17(4). 679–84. 6 indexed citations

17.

Street, Maria Elisabeth, Farideh Miraki‐Moud, Ian R. Sanderson, et al.. (2003). Interleukin-1beta (IL-1beta) and IL-6 modulate insulin-like growth factor-binding protein (IGFBP) secretion in colon cancer epithelial (Caco-2) cells. Journal of Endocrinology. 179(3). 405–415. 32 indexed citations

18.

Saksena, Mansi A., et al.. (2002). Effect of insulin-like growth factor binding protein-3 (IGFBP-3) on colon cancer epithelial cells growth and apoptosis. 1 indexed citations

19.

Miraki‐Moud, Farideh, Paul J. Jenkins, P D Fairclough, et al.. (2001). Increased levels of insulin‐like growth factor binding protein‐2 in sera and tumours from patients with colonic neoplasia with and without acromegaly. Clinical Endocrinology. 54(4). 499–508. 28 indexed citations

20.

Aguiar‐Oliveira, Manuel H., Matthew S. Gill, Antônio Carlos Pereira Barretto, et al.. (1999). Effect of Severe Growth Hormone (GH) Deficiency due to a Mutation in the GH-Releasing Hormone Receptor on Insulin-Like Growth Factors (IGFs), IGF-Binding Proteins, and Ternary Complex Formation Throughout Life1. The Journal of Clinical Endocrinology & Metabolism. 84(11). 4118–4126. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact